Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bisirna Therapeutics (suzhou) Co., Ltd.

Clinical trials sponsored by Bisirna Therapeutics (suzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New injection targets hidden heart risk in early trial Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Not yet finished but already full! 2

New complement inhibitor takes on established PNH drug in phase III trial

Disease control Not yet recruiting

Researchers are testing an experimental drug called VSA012 against eculizumab in adults with paroxysmal nocturnal hemoglobinuria (PNH) who have not received complement inhibitor therapy. The trial enrolls about 70 participants and compares how well each treatment controls hemolys…

Phase 3 • Sponsor: Bisirna Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC